Skip to lesson
OncoGuideeducationDiana’s wiki
THE EDUCATION LIBRARY

B cells and plasma cells

In one sentence

B cells participate in antigen recognition and immune responses, while plasma cells are differentiated members of the B-cell lineage specialized for antibody secretion.

The intuition

A B-cell response is like a workshop that can recognize an order, develop a better tool and produce many copies. Plasma cells specialize in production. Other B cells can retain memory or participate in immune conversations.

The analogy stops before a guaranteed product: a cell's presence does not reveal what its antibody recognizes or whether that response helps control cancer.

How it works

A developing B cell assembles an antigen-receptor sequence through V(D)J recombination. Its B-cell receptor (BCR) includes membrane-bound immunoglobulin, another name for antibody. Recognition involves an accessible molecular feature, unlike a conventional T-cell receptor's peptide–human leukocyte antigen recognition.

Recognition and activation are separate. For many protein antigens, B cells receive help from suitable CD4 T cells. B cells can internalize recognized material and present fragments to these helpers. Other antigen contexts can support responses with less direct T-cell help. “All B cells require the same help” would erase that distinction.

An activated response can produce memory B cells and antibody-secreting cells. A plasmablast is an early antibody-secreting stage that can still divide. Plasma cells specialize further in secretion. Some are short-lived; others persist in supportive tissue niches. Memory B cells and persistent plasma cells are different ways a response can leave a lasting trace.

Differentiation changes the cell's gene program and machinery. Shapiro-Shelef and colleagues showed that deleting the gene for the regulator Blimp-1 in mouse B cells strongly impaired plasma-cell formation and antibody secretion. Having B cells that respond to antigen was not enough to establish normal secretion. This is a mechanistic mouse experiment, not a human tumor biomarker rule.

Some responses pass through germinal centers, organized areas where B-cell variants undergo selection. Class switching changes antibody class; sequence changes and selection can alter binding quality. These are different processes, and not every secreting cell comes from the same developmental route.

B-cell recognitionand response context Activated B-cell response Memory B cells Antibody-secreting cells Plasma-cell secretionand possible persistence

This is a simplified response map, not a compulsory path for every B cell.

Why it matters in cancer

B cells can present material, supply signals and generate antibodies. Plasma cells can contribute substantial antibody RNA to a tumor sample. A high immunoglobulin signal therefore does not automatically originate from cancer cells.

B cells may occur in tertiary lymphoid structures, organized immune gatherings outside native lymphoid organs. Architecture, specificity and local function matter alongside abundance. Neither “more B cells” nor “more antibodies” is a universal benefit rule.

How it is measured

Flow cytometry and spatial staining use marker combinations to distinguish populations. Marker patterns change during differentiation; a panel identifying ordinary B cells may miss some plasma cells. Preserve the phenotype definition and denominator.

RNA can reveal an antibody-production program or receptor sequence. Serum assays can measure antibody concentrations and classes. To ask what an antibody recognizes, use antigen-specific binding and suitable functional experiments. Total concentration or class alone cannot answer that question.

Common confusions

  • Plasma cells are cells; blood plasma is the fluid portion of blood.
  • Memory B cells are not simply plasma cells waiting to secrete.
  • Antibody-class RNA does not identify the antibody's antigen.
  • A lymphocyte cluster is not automatically a mature germinal center.

Try it

A fictional tumor's RNA report contains many immunoglobulin A messages. Can the team conclude that cancer cells make a cancer-specific antibody?

Answer: No. Antibody-secreting immune cells may supply the messages. Cell attribution and antigen specificity require different evidence.

Sources and scope

Source check: October 9, 2026. Lineage, differentiation and interpretation; fictional practice, no tumor-response cutoff. Expert and learner review remain pending.

Used in